dipyridamole has been researched along with Hypertension, Renovascular in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Hypertension, Renovascular: Hypertension due to RENAL ARTERY OBSTRUCTION or compression.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Steensma-Vegter, AJ | 1 |
| Krediet, RT | 1 |
| Westra, D | 1 |
| Tegzess, AM | 1 |
1 other study available for dipyridamole and Hypertension, Renovascular
| Article | Year |
|---|---|
Reversible stenosis of the renal artery in cadaver kidney grafts: a report of three cases.
Topics: Antihypertensive Agents; Cadaver; Dipyridamole; Female; Humans; Hypertension, Renovascular; Kidney F | 1981 |